Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 21, 2010

Premium

Aushon BioSystems last week named Johann de Bono, John Heymach, Gavin MacBeath, and Gordon Mills to its newly formed scientific advisory board.

De Bono is a consultant in medical oncology at the Royal Marsden Hospital and Institute of Cancer Research in London.

Heymach is an associate professor of thoracic head/neck medical oncology and cancer biology at the University of Texas MD Anderson Cancer Center, and he is director of the Thoracic Blood Biomarker Laboratory at the hospital.

MacBeath is senior director and head of translational research and co-founder at Merrimack Pharmaceuticals, and he was a faculty member in the department of chemistry and chemical biology at Harvard University.

Mills is university chair in cancer medicine, chair of the department of systems biology in the division of cancer medicine, and co-head of the Kleberg Center for Molecular Markers at MD Anderson.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.